All In Biotech

Drug Trial Radar · NCT07156617

A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data

Last checked: Nov 19, 2026Latest source record: Sep 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

2,000

Planned (sponsor's estimate)

Start

Oct 1, 2025

Primary completion

Oct 1, 2027

Study completion Oct 1, 2028

Sponsor

Lead sponsor
Xuhua DuanAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 5, 2025

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The system assesses the heterogeneity of HCC patients in terms of therapeutic outcomes (such as rwPFS, ORR, PRO) and adverse reactions during the process of interventional therapy combined with systemic treatment. It explores the clinical characteristics and biomarker levels of patients related to heterogeneity and builds a machine learning model to predict the risk of adverse reactions, providing evidence support for the construction of a patient-centered individualized decision-making system.

Conditions

  • Hepatocellular Carcinoma (HCC)

Interventions

  • Interventional therapyProcedure

    Interventional therapy

  • Systemic therapyDrug

    Targeted Therapy drugs include but are not limited to Lenvatinib, Apatinib, etc. Immunotherapy drugs include but are not limited to Camrelizumab, Tislelizumab

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. rwPFSTime frame: up to 2 years

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Second People's Hospital of Jiaozuo

    Jiaozuo, China

  • The Second Affiliated Hospital of Hainan Medical Universsity

    Haikou, Hainan, China

  • Xingtai No.5 Hospital

    Xingtai, Hebei, China

  • Deng zhou People's Hospital

    Dengzhou, Henan, China

  • The Second People's Hospital of Jiaozuo

    Jiaozuo, Henan, China

  • Huai He Hospital of Henan University

    Kaifeng, Henan, China

  • Luo Yang Central Hospital

    Luoyang, Henan, China

  • The First Affiliated Hospital of Henan University of science and Technology

    Luoyang, Henan, China

  • First People's Hospital of Shangqiu

    Shangqiu, Henan, China

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • Zhou Kou Central Hospital

    Zhoukou, Henan, China

  • Wuxi No.5 People's Hospital

    Wuxi, Jiangsu, China

  • Jiangxi Provincial People's Hospitail

    Nanchang, Jiangxi, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.